Signal #144092 · SEC 8-K

$LXRX SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $LXRX filing catalyst

Why did $LXRX trigger an AI stock catalyst alert?

$LXRX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.5/10). Headline: Lexicon Pharmaceuticals Q3 Revenue Drops to $11.3M, Net Loss Widens to $14.0M. Key points: - Total Q3 revenue dropped YoY from $14.2M to $11.3M, heavily reliant on a $10M Novo milestone. - Net loss widened to $14.0M ($0.03/share) compared to $12.8M in Q3 prior year. - INPEFA net sales remain modest at $1.2M; Phase 3 SONATA-HCM top-line data guided for Q1 2027.

How did $LXRX stock react after the SEC filing?

After the SEC 8-K for $LXRX, observed market reaction: T0 price $1.48. Past moves do not guarantee future results.

Where can I get real-time $LXRX SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $LXRX via Telegram and the VIP Web Terminal from €10/month.

$LXRX

$LXRX – Lexicon Pharmaceuticals Q3 Revenue Drops to $11.3M, Net Loss Widens to $14.0M

LEXICON PHARMACEUTICALS, INC.

2026-11-05 00:00:00 UTC · SEC 8-K · All $LXRX

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-1.5 / 10)

Total Q3 revenue dropped YoY from $14.2M to $11.3M, heavily reliant on a $10M Novo milestone.
Net loss widened to $14.0M ($0.03/share) compared to $12.8M in Q3 prior year.
INPEFA net sales remain modest at $1.2M; Phase 3 SONATA-HCM top-line data guided for Q1 2027.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →